Welcome to the Future of mRNA Process Development & Manufacturing
The 2nd mRNA Process Development & Manufacturing Summit returned to Boston as the most comprehensive and technical industry dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design and automated large-scale manufacturing, to ultimately reduce costs of mRNA production whilst harmonizing with regulatory expectations.
60+ world-class industry experts including leading mRNA players from Moderna, BioNTech, CureVac, Pfizer and more took center stage across 3 jam-packed days, with 3 deep-dive content tracks on research scale, IND-enabling & clinical scale, and commercial scale covering key areas from plasmid DNA manufacturing, in vitro transcription, purification and mRNA drug product development to help accelerate your mRNA drugs into the clinic and through to market.
Attendees were able to join 200+ VPs, Directors and Heads of Process Development, Drug Substance, CMC, and MSAT at the world’s only end-to-end meeting enabling scalable, cost-effective and commercially viable global mRNA production.
The 2023 Expert Speaker Faculty Included:
Senior Vice President - Ribonucleic Acid Biochemistry & Chemistry, Manufacturing, Controls Management
Senior Principal Scientist Group Leader
VP Process Development & RNA Technology
Director - Manufacturing Science & Technology
Director – Process Development
Associate Director - Regulatory Affairs CMC
Vice President, Head of Messenger Ribonucleic Acid PD, Manufacturing, Science & Technology , & Program Management Offices
Head of Biochemistry – Analytical Development, mRNA Centre of Excellence